Elromo 25mg Tablet dubbl

1. Product Introduction

Elromo 25mg Tablet dubbl is a prescription medicine containing Eltrombopag, a thrombopoietin receptor agonist. It is used primarily to treat low blood platelet counts in certain medical conditions, such as chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia (SAA). The tablet works by stimulating the bone marrow to produce more platelets, helping prevent bleeding episodes in patients with abnormally low platelet counts.

This medicine is especially beneficial for patients who have had inadequate responses to other treatments like corticosteroids, immunoglobulins, or splenectomy. Elromo 25mg is an oral tablet, making it a convenient alternative to injectable treatments. It must be used under strict medical supervision, with regular monitoring of platelet levels and liver function.

2. Uses of Elromo 25mg Tablet dubbl

Elromo 25mg Tablet dubbl is used in the treatment of the following conditions:

• Chronic Immune Thrombocytopenia (ITP):
  For adults and children (aged 1 year and above) with ITP who have not responded adequately to other therapies. ITP is an autoimmune disorder that leads to low platelet levels and increased risk of bleeding.

• Thrombocytopenia in Hepatitis C Patients:
  Used to treat low platelet counts in patients with chronic hepatitis C infection to allow the initiation and maintenance of interferon-based therapy.

• Severe Aplastic Anemia (SAA):
  For patients with SAA who are either refractory to immunosuppressive therapy or as a first-line treatment in combination with standard immunosuppressive therapy.

• Off-label Uses (under doctor’s supervision):
  In rare cases, it may be prescribed in other conditions associated with thrombocytopenia or bone marrow suppression.

3. Benefits of Elromo 25mg Tablet dubbl

• Improves Platelet Production:
  Elromo helps to boost platelet levels by stimulating thrombopoietin receptors in the bone marrow, reducing the need for blood transfusions or platelet transfusions.

• Reduces Risk of Bleeding:
  Patients with very low platelet counts are at high risk for spontaneous bleeding. By increasing platelet count, Elromo significantly reduces the risk of internal and external bleeding.

• Allows Continuation of Therapy:
  In hepatitis C patients, low platelets often prevent continuation of antiviral therapy. Elromo helps maintain platelet levels, allowing uninterrupted antiviral treatment.

• Effective in Refractory Conditions:
  Especially beneficial for patients who do not respond to conventional therapies like steroids or splenectomy, offering a newer, targeted approach.

• Oral Administration:
  Being a tablet, it avoids the discomfort of injections and can be taken conveniently at home under physician guidance.

4. Side Effects

While Elromo 25mg is generally well-tolerated, some patients may experience side effects. These can be mild to moderate but should be reported to the doctor, especially if persistent.

Common Side Effects:

• Nausea or vomiting

• Headache

• Fatigue

• Diarrhea

• Upper respiratory tract infection

• Muscle aches

Serious Side Effects (Seek immediate medical attention):

• Liver Toxicity: May cause elevated liver enzymes; regular liver function monitoring is advised.

• Thromboembolic Events: Excessively high platelet counts may lead to clotting problems, such as deep vein thrombosis or stroke.

• Cataracts: Long-term use may increase the risk of cataract formation.

• Bone Marrow Fibrosis: Rarely, long-term use can lead to bone marrow scarring.

Important Precautions:

• Do not use without regular blood tests.

• Inform your doctor if you have liver problems.

• Do not take with dairy or calcium-rich foods, as they interfere with absorption.

• Avoid self-medication or dosage changes without consulting your healthcare provider.

5. Frequently Asked Questions (FAQs)

Q1. How does Elromo 25mg Tablet dubbl work?
Elromo contains Eltrombopag, which activates the thrombopoietin receptors in the bone marrow, promoting the production of platelets and reducing bleeding risks.

Q2. Can I take Elromo 25mg with food?
It should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal. Avoid dairy products or calcium supplements close to the dose, as they can hinder its absorption.

Q3. How long will I need to take this medicine?
The duration depends on your condition and response. Some patients may require long-term therapy, while others might use it short-term. Your doctor will guide you based on regular monitoring.

Q4. What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it’s close to the next scheduled dose, skip the missed one. Do not double the dose.

Q5. Is Elromo 25mg safe during pregnancy or breastfeeding?
No, it is not recommended for use during pregnancy or breastfeeding unless prescribed by your doctor after assessing the risks and benefits.

References